LOGIN
Thrombin-JMI in TKA minimizes hemoglobin reduction but may not be cost effective
December 2013
Thrombin-JMI in TKA minimizes hemoglobin reduction but may not be cost effective
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Use of bovine thrombin to reduce blood loss in primary total knee arthroplasty: a controlled randomized trial
J Arthroplasty. 2013 Sep;28(8):1278-81Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
80 osteoarthritic patients, aged 18 years and older, undergoing total knee arthroplasty were randomized to evaluate the efficacy of bovine thrombin (Thrombin-JMI), over 2 years, in improving blood loss parameters, total drain output, transfusion requirements, length of stay, bleeding related complications and Knee Society Scores (KSS), during and after surgery. The evidence presented in this study...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.